Diagnostic Considerations

In the setting of asymptomatic sinus bradycardia, implantation of a VVI pacemaker may induce symptoms of pacemaker syndrome. Even though this may be a class 2a indication for pacemaker implantation, the potential exists for worsening of quality of life. Thus, individuals may develop a subjectively worse quality of life with ventricular pacing than they had prior to pacemaker implantation, or they may endure a persistently degraded quality of life, as suggested by Sulke's study of subclinical pacemaker syndrome.

Other conditions to be considered in patients with suspected pacemaker syndrome include the following:

Pacemaker malfunction
Inappropriate mode switching
Worsening heart failure, unrelated to pacemaker function
Recent change in medications, particularly antihypertensives
Paroxysmal atrial fibrillation
Dehydration
Neurocardiogenic syncope
Postural orthostatic hypotension syndrome
Inappropriate sinus tachycardia (common in young women survivors of childhood sex abuse)
Infection, particularly upper respiratory infection, pneumonia
Autonomic dysfunction
Adrenal insufficiency

Differential Diagnoses

Workup

McWilliam JA. Electrical stimulation of the heart in man. Br Med J. 1889 Feb 16. 1(1468):348-50. [QxMD MEDLINE Link]. [Full Text].
Alicandri C, Fouad FM, Tarazi RC, et al. Three cases of hypotension and syncope with ventricular pacing: possible role of atrial reflexes. Am J Cardiol. 1978 Jul. 42(1):137-42. [QxMD MEDLINE Link].
Erbel R. Pacemaker syndrome. Am J Cardiol. 1979 Oct. 44(4):771-2. [QxMD MEDLINE Link].
Erlebacher JA, Danner RL, Stelzer PE. Hypotension with ventricular pacing: an atria vasodepressor reflex in human beings. J Am Coll Cardiol. 1984 Sep. 4(3):550-5. [QxMD MEDLINE Link].
Mitsui T, Hori M, Suma K, et al. The "pacemaking syndrome". In: Jacobs JE, ed. Proceedings of the 8th Annual International Conference on Medical and Biological Engineering. Chicago, IL: Association for the Advancement of Medical Instrumentation; 1969. 29-3.
Mitsui T, Mizuno A, Hasegawa T, et al. Atrial rate as an indicator for optimal pacing rate and the pacemaking syndrome. Ann Cardiol Angeiol (Paris). 1971 Jul-Aug. 20(4):371-9. [QxMD MEDLINE Link].
Furman S. Pacemaker syndrome. Pacing Clin Electrophysiol. 1994 Jan. 17(1):1-5. [QxMD MEDLINE Link].
Ellenbogen KA, Gilligan DM, Wood MA, et al. The pacemaker syndrome -- a matter of definition. Am J Cardiol. 1997 May 1. 79(9):1226-9. [QxMD MEDLINE Link].
Gross JN, Keltz TN, Cooper JA, et al. Profound "pacemaker syndrome" in hypertrophic cardiomyopathy. Am J Cardiol. 1992 Dec 1. 70(18):1507-11. [QxMD MEDLINE Link].
[Guideline] Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008 May 27. 51(21):e1-62. [QxMD MEDLINE Link]. [Full Text].
[Guideline] Tracy CM, Epstein AE, Darbar D, et al. 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. [corrected]. Circulation. 2012 Oct 2. 126(14):1784-800. [QxMD MEDLINE Link]. [Full Text].
Lamas GA, Orav EJ, Stambler BS, et al. Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. Pacemaker Selection in the Elderly Investigators. N Engl J Med. 1998 Apr 16. 338(16):1097-104. [QxMD MEDLINE Link].
Sulke N, Chambers J, Dritsas A, Sowton E. A randomized double-blind crossover comparison of four rate-responsive pacing modes. J Am Coll Cardiol. 1991 Mar 1. 17(3):696-706. [QxMD MEDLINE Link].
Hargreaves MR, Channon KM, Cripps TR, et al. Comparison of dual chamber and ventricular rate responsive pacing in patients over 75 with complete heart block. Br Heart J. 1995 Oct. 74(4):397-402. [QxMD MEDLINE Link].
Oldroyd KG, Rae AP, Carter R, et al. Double blind crossover comparison of the effects of dual chamber pacing (DDD) and ventricular rate adaptive (VVIR) pacing on neuroendocrine variables, exercise performance, and symptoms in complete heart block. Br Heart J. 1991 Apr. 65(4):188-93. [QxMD MEDLINE Link].
Lee TM, Su SF, Lin YJ, et al. Role of transesophageal echocardiography in the evaluation of patients with clinical pacemaker syndrome. Am Heart J. 1998 Apr. 135(4):634-40. [QxMD MEDLINE Link].
Theodorakis GN, Kremastinos DT, Markianos M, et al. Total sympathetic activity and atrial natriuretic factor levels in VVI and DDD pacing with different atrioventricular delays during daily activity and exercise. Eur Heart J. 1992 Nov. 13(11):1477-81. [QxMD MEDLINE Link].
Theodorakis GN, Panou F, Markianos M, et al. Left atrial function and atrial natriuretic factor/cyclic guanosine monophosphate changes in DDD and VVI pacing modes. Am J Cardiol. 1997 Feb 1. 79(3):366-70. [QxMD MEDLINE Link].
Nishimura RA, Gersh BJ, Vlietstra RE, et al. Hemodynamic and symptomatic consequences of ventricular pacing. Pacing Clin Electrophysiol. 1982 Nov. 5(6):903-10. [QxMD MEDLINE Link].
Rosenqvist M, Isaaz K, Botvinick EH, et al. Relative importance of activation sequence compared to atrioventricular synchrony in left ventricular function. Am J Cardiol. 1991 Jan 15. 67(2):148-56. [QxMD MEDLINE Link].
Bordachar P, Lafitte S, Reuter S, et al. Echocardiographic parameters of ventricular dyssynchrony validation in patients with heart failure using sequential biventricular pacing. J Am Coll Cardiol. 2004 Dec 7. 44(11):2157-65. [QxMD MEDLINE Link].
Mollazadeh R, Mohimi L, Zeighami M, et al. Hemodynamic effect of atrioventricular and interventricular dyssynchrony in patients with biventricular pacing: implications for the pacemaker syndrome. J Cardiovasc Dis Res. 2012 Jul. 3(3):200-3. [QxMD MEDLINE Link]. [Full Text].
Poller WC, Dreger H, Schwerg M, Melzer C. Prevalence of E/A wave fusion and A wave truncation in DDD pacemaker patients with complete AV block under nominal AV intervals. PLoS One. 2015. 10(2):e0116075. [QxMD MEDLINE Link]. [Full Text].
Link MS, Hellkamp AS, Estes NA, et al. High incidence of pacemaker syndrome in patients with sinus node dysfunction treated with ventricular-based pacing in the Mode Selection Trial (MOST). J Am Coll Cardiol. 2004 Jun 2. 43(11):2066-71. [QxMD MEDLINE Link].
Schuller H, Brandt J. The pacemaker syndrome: old and new causes. Clin Cardiol. 1991 Apr. 14(4):336-40. [QxMD MEDLINE Link].
Torresani J, Ebagosti A, Allard-Latour G. Pacemaker syndrome with DDD pacing. Pacing Clin Electrophysiol. 1984 Nov. 7(6 Pt 2):1148-51. [QxMD MEDLINE Link].
Jais P, Barold S, Shah DC, et al. Pacemaker syndrome induced by the mode switching algorithm of a DDDR pacemaker. Pacing Clin Electrophysiol. 1999 Apr. 22(4 Pt 1):682-5. [QxMD MEDLINE Link].
Grant JD, Jensen GL, Tang C, et al. Radiotherapy-induced malfunction in contemporary cardiovascular implantable electronic devices: clinical incidence and predictors. JAMA Oncol. 2015 Aug. 1(5):624-32. [QxMD MEDLINE Link]. [Full Text].
Pascale P, Pruvot E, Graf D. Pacemaker syndrome during managed ventricular pacing mode: what is the mechanism?. J Cardiovasc Electrophysiol. 2009 May. 20(5):574-6. [QxMD MEDLINE Link].
Barold SS, Herweg B. The effect of hyperkalaemia on cardiac rhythm devices. Europace. 2014 Apr. 16(4):467-76. [QxMD MEDLINE Link].
Ausubel K, Furman S. The pacemaker syndrome. Ann Intern Med. 1985 Sep. 103(3):420-9. [QxMD MEDLINE Link].
Heldman D, Mulvihill D, Nguyen H, et al. True incidence of pacemaker syndrome. Pacing Clin Electrophysiol. 1990 Dec. 13(12 Pt 2):1742-50. [QxMD MEDLINE Link].
Sulke N, Dritsas A, Bostock J, et al. "Subclinical" pacemaker syndrome: a randomised study of symptom free patients with ventricular demand (VVI) pacemakers upgraded to dual chamber devices. Br Heart J. 1992 Jan. 67(1):57-64. [QxMD MEDLINE Link].
Frielingsdorf J, Gerber AE, Hess OM. Importance of maintained atrio-ventricular synchrony in patients with pacemakers. Eur Heart J. 1994 Oct. 15(10):1431-40. [QxMD MEDLINE Link].
Sutton R, Kenny RA. The natural history of sick sinus syndrome. Pacing Clin Electrophysiol. 1986 Nov. 9(6 Pt 2):1110-4. [QxMD MEDLINE Link].
Hesselson AB, Parsonnet V, Bernstein AD, Bonavita GJ. Deleterious effects of long-term single-chamber ventricular pacing in patients with sick sinus syndrome: the hidden benefits of dual-chamber pacing. J Am Coll Cardiol. 1992 Jun. 19(7):1542-9. [QxMD MEDLINE Link].
Santini M, Alexidou G, Ansalone G, et al. Relation of prognosis in sick sinus syndrome to age, conduction defects and modes of permanent cardiac pacing. Am J Cardiol. 1990 Mar 15. 65(11):729-35. [QxMD MEDLINE Link].
Sasaki Y, Furihata A, Suyama K, et al. Comparison between ventricular inhibited pacing and physiologic pacing in sick sinus syndrome. Am J Cardiol. 1991 Apr 1. 67(8):771-4. [QxMD MEDLINE Link].
Rosenqvist M, Brandt J, Schuller H. Long-term pacing in sinus node disease: effects of stimulation mode on cardiovascular morbidity and mortality. Am Heart J. 1988 Jul. 116(1 Pt 1):16-22. [QxMD MEDLINE Link].
Andersen HR, Nielsen JC, Thomsen PE, et al. Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome. Lancet. 1997 Oct 25. 350(9086):1210-6. [QxMD MEDLINE Link].
Zanini R, Facchinetti A, Gallo G, et al. Survival rates after pacemaker implantation: a study of patients paced for sick sinus syndrome and atrioventricular block. Pacing Clin Electrophysiol. 1989 Jul. 12(7 Pt 1):1065-9. [QxMD MEDLINE Link].
Alpert MA, Curtis JJ, Sanfelippo JF, et al. Comparative survival after permanent ventricular and dual chamber pacing for patients with chronic high degree atrioventricular block with and without preexistent congestive heart failure. J Am Coll Cardiol. 1986 Apr. 7(4):925-32. [QxMD MEDLINE Link].
Bush DE, Finucane TE. Permanent cardiac pacemakers in the elderly. J Am Geriatr Soc. 1994 Mar. 42(3):326-34. [QxMD MEDLINE Link].
Iqbal AM, Jamal SF. Pacemaker syndrome. StatPearls [Internet]. 2022 Jan. [QxMD MEDLINE Link]. [Full Text].
Kastrup EK, Hebel SK, Olin BR. Drug Facts and Comparisons. 55th ed. 2001. 1275-88.
Sharma PS, Kaszala K, Tan AY, et al. Repetitive nonreentrant ventriculoatrial synchrony: an underrecognized cause of pacemaker-related arrhythmia. Heart Rhythm. 2016 Aug. 13(8):1739-47. [QxMD MEDLINE Link].

Media Gallery

Pacemaker Syndrome. Pacemaker syndrome without pacemaker participation. Displayed are stored data from a dual-chamber pacemaker. The intracardiac tracings reveal atrial tachycardia with second-degree AV block that together created continuous atrioventricular (AV) dyssynchrony, leading to symptoms of pacemaker syndrome, including fatigue, lightheadedness, and exertional dyspnea. Notice that the pacemaker does not participate in creation of AV dyssynchrony. There are no paced events. Top tracing: atrial electrogram. Middle tracing: ventricular electrogram. Bottom tracing: channel markers. Ab = atrial sensed event in postventricular blanking period, AR = atrial sensed event in postventricular refractory period; VS – Ventricular sensed event.
Pacemaker Syndrome. Pronounced PR interval prolongation. The effect of this PR interval prolongation on AV dyssynchrony is demonstrated in this ECG image.
Pacemaker Syndrome. AV dyssynchrony resulting from severe PR interval prolongation in the setting of sinus rhythm. In this ECG, the PR interval is prolonged to the point that the P wave occurs coincident with the peak of the T wave. Compare to the prior image of the same patient with a slower sinus rate.
Pacemaker Syndrome. Accelerated idioventricular rhythm with retrogradely conducted P waves. This ECG demonstrates a mechanism of AV dyssynchrony that might lead to pseudopacemaker syndrome.
Pacemaker Syndrome. Junctional rhythm with retrogradely conducted P waves. If symptoms of pacemaker syndrome develop, increasing the lower rate limit for pacing may help to restore AV synchrony.
Pacemaker Syndrome. Retrogradely conducted P waves are visible directly following each ventricular-paced complex.
Pacemaker Syndrome. This is an ECG tracing of a patient with continuous atrioventricular synchronous (DDD) pacing prior to development of symptoms. Atrial stimulation (open arrows) is followed by visible P waves. Wide QRS complexes follow ventricular stimulation (solid arrows).
Pacemaker Syndrome. This is an ECG tracing of a patient with atrioventricular (AV) dissociation and resultant pacemaker syndrome. Native atrial depolarizations (arrows) move progressively closer to pacemaker-stimulated ventricular depolarizations. Ventricular pacemaker stimuli (arrowheads) are greater in amplitude than those visible in the previous image, consistent with mode reversion from AV synchronous (DDD) to ventricular inhibited (VVI), which includes a switch from bipolar pacing (low amplitude) to unipolar pacing (higher amplitude).

of 8

Study	Patients (number)	Total Incidence (%)			Follow-up (years)	Annual Incidence (%)
		VVI	AAI	DDD		VVI	AAI	DDD
Frielingsdorf^[34]	1838	18-47	0-17*		3.75	4.8-12.5	0-4.5*
Sutton and Kenny^[35]	1061	22	3.9		AAI: 2.75 VVI: 3.25	6.77	1.42
Hesselson^[36]	8827	14-57	0-23		AAI: 1-8 VVI: 3-8	Cannot be determined
Hesselson^[36]	950	38	7		7	5.43	1.00
Santini^[37]	339	48	3.7	13	5	9.6	0.74	2.6
Sasaki^[38]	75	41	2*		AAI: 3.25 VVI: 5.17	7.9	0.62*
Rosenqvist^[39]	168	47	6.7		4	11.8	1.68
*Combined AAI and DDD

Pacemaker Syndrome Differential Diagnoses

Diagnostic Considerations

Differential Diagnoses

References

Tables

Contributor Information and Disclosures

What would you like to print?